. Author manuscript; available in PMC: 2018 Jun 1.

Published in final edited form as: J Mol Cell Cardiol. 2017 Apr 27;107:41–51. doi: 10.1016/j.yjmcc.2017.04.004

Table 1E.

Hemodynamic parameters EDC treatment in esERα-WT and -KO

Heart samples			Pre-ischemic equilibration			Post-ischemic/End of reperfusion

	(n)	Body weight (g)	FR (ml/min)	HR (bpm)	LVDP (cmH₂O)	FR (ml/min)	HR (bpm)	LVDP (cmH₂O)
es-ERαWT	5	23±0.3	2.2±0.1	365±5.3	138±3	1.7±0.1	294±9	49±4^#
es-ERαWT + EDC	6	22±0.5	2.2±0.1	355±17	121±9	1.6±0.01	329±21	62±4
es-ERαKO	6	23±0.8	2.0±0.1	344±16	129±8	1.6±0.1	302±6	41±2
es-ERαKO + EDC	7	23±0.5	2.1±0.1	375±11	125±7	1.6±0.1	304±13	47±4

Values are mean ± SE; (n), number of hearts; FR, flow rate (ml/min); HR, heart rate (beats per min, bpm); LVDP, left ventricular developed pressure.

p<0.05 vs the same genotype + EDC.